Green Thumb Industries (GTBIF) Share-based Compensation (2019 - 2026)
Green Thumb Industries' (GTBIF) quarterly Share-based Compensation came in at $50.5 million in Q1 2026, up 390.31% YoY from $10.3 million in Q1 2025, and up 333.72% on a QoQ basis from $11.7 million in Q3 2025.
Green Thumb Industries (GTBIF) Share-based Compensation (2019 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 8 years of Share-based Compensation data on file, last reported at $50.5 million in Q1 2026.
- Quarterly Share-based Compensation rose 390.31% year-over-year to $50.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $50.5 million (up 36.13% YoY) and the FY2025 annual result came in at $61.4 million, down 20.75% from the prior year.
- Share-based Compensation improved to $50.5 million in Q1 2026, from $11.7 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $50.5 million in Q1 2026 to a low of $6.2 million in Q1 2023.
- A 5-year average of $11.3 million and a median of $8.1 million in 2022 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2023 — Share-based Compensation sank 52.41% — and 2026, when it soared 390.31%.
- Tracing GTBIF's Share-based Compensation over 5 years: stood at $7.8 million in 2022, then slipped by 5.45% to $7.4 million in 2023, then soared by 30.64% to $9.6 million in 2024, then climbed by 21.31% to $11.7 million in 2025, then jumped by 333.72% to $50.5 million in 2026.
- The last three Share-based Compensation figures came in at $50.5 million (Q1 2026), $11.7 million (Q3 2025), and $12.0 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn | 10.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.62 Mn |
| Jun 30, 2026 | 10.62 Mn |
| Mar 31, 2026 | 50.55 Mn |
| Mar 31, 2026 | 50.55 Mn |
| Sep 30, 2025 | 11.65 Mn |
| Sep 30, 2025 | 11.65 Mn |
| Jun 30, 2025 | 11.97 Mn |
| Jun 30, 2025 | 11.97 Mn |
| Mar 31, 2025 | 10.31 Mn |
| Mar 31, 2025 | 10.31 Mn |
| Dec 31, 2024 | 9.61 Mn |
| Dec 31, 2024 | 9.61 Mn |
| Sep 30, 2024 | 8.35 Mn |
| Sep 30, 2024 | 8.35 Mn |
| Jun 30, 2024 | 8.87 Mn |
| Jun 30, 2024 | 8.87 Mn |
| Mar 31, 2024 | 6.49 Mn |
| Mar 31, 2024 | 6.49 Mn |
| Dec 31, 2023 | 7.35 Mn |
| Dec 31, 2023 | 7.35 Mn |